These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 10945293)
1. Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats. Murakami Y; Tateyama S; Rungsipipat A; Uchida K; Yamaguchi R J Vet Med Sci; 2000 Jul; 62(7):743-50. PubMed ID: 10945293 [TBL] [Abstract][Full Text] [Related]
2. Amplification of the cyclin A gene in canine and feline mammary tumors. Murakami Y; Tateyama S; Rungsipipat A; Uchida K; Yamaguchi R J Vet Med Sci; 2000 Jul; 62(7):783-7. PubMed ID: 10945302 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of P53 overexpression in paraffin wax-embedded squamous cell carcinomas of cattle, horses, cats and dogs. Teifke JP; Löhr CV J Comp Pathol; 1996 Feb; 114(2):205-10. PubMed ID: 8920221 [TBL] [Abstract][Full Text] [Related]
4. Four cases of cell cannibalism in highly malignant feline and canine tumors. Ferreira FC; Soares MJ; Carvalho S; Borralho L; Vicente G; Branco S; Correia J; Peleteiro MC Diagn Pathol; 2015 Nov; 10():199. PubMed ID: 26525147 [TBL] [Abstract][Full Text] [Related]
5. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53. Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357 [TBL] [Abstract][Full Text] [Related]
6. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors. Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983 [TBL] [Abstract][Full Text] [Related]
7. Coordinate expression of cytokeratins 7 and 20 in feline and canine carcinomas. Espinosa de los Monteros A; Fernández A; Millán MY; Rodríguez F; Herráez P; Martín de las Mulas J Vet Pathol; 1999 May; 36(3):179-90. PubMed ID: 10332826 [TBL] [Abstract][Full Text] [Related]
8. Molecular phenotype of primary mammary tumours and distant metastases in female dogs and cats. Beha G; Muscatello LV; Brunetti B; Asproni P; Millanta F; Poli A; Benazzi C; Sarli G J Comp Pathol; 2014; 150(2-3):194-7. PubMed ID: 24060151 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of Mdm2 and p53 in feline mammary gland tumors. Nakano M; Wu H; Taura Y; Inoue M J Vet Med Sci; 2006 May; 68(5):421-5. PubMed ID: 16757883 [TBL] [Abstract][Full Text] [Related]
10. Metallothionein expression in canine and feline mammary and melanotic tumours. Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128 [TBL] [Abstract][Full Text] [Related]
11. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892 [TBL] [Abstract][Full Text] [Related]
12. Lectin histochemistry on squamous metaplasia in different epithelial tumors of dogs. Castagnaro M; Canese MG Vet Pathol; 1991 Jan; 28(1):8-15. PubMed ID: 1708179 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of COX-2 in feline and canine actinic keratoses and cutaneous squamous cell carcinoma. Bardagí M; Fondevila D; Ferrer L J Comp Pathol; 2012 Jan; 146(1):11-7. PubMed ID: 21601872 [TBL] [Abstract][Full Text] [Related]
14. CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis. Ferrari A; Petterino C; Ratto A; Campanella C; Wurth R; Thellung S; Vito G; Barbieri F; Florio T BMC Vet Res; 2012 Mar; 8():27. PubMed ID: 22417013 [TBL] [Abstract][Full Text] [Related]
15. Pathological and Immunohistochemical Microscopy of Natural Cases of Canine and Feline Neoplastic Mammary Lesions. Tawfik MF; Oda SS; Khafaga AF Microsc Microanal; 2021 Aug; 27(4):910-922. PubMed ID: 34128458 [TBL] [Abstract][Full Text] [Related]
16. In vitro growth inhibition activities of recombinant feline interferon on all lines derived from canine tumours. Tateyama S; Priosoeryanto BP; Yamaguchi R; Uchida K; Ogiwara K; Suchiya AT Res Vet Sci; 1995 Nov; 59(3):275-7. PubMed ID: 8588106 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology and classification for canine and feline mammary gland tumors: a histopathological survey of 437 mammary gland tumor biopsies performed in a secondary care hospital in Chiang Mai, Thailand from 2012 to 2019. Srisawat W; Pringproa K; Prachasilchai W; Thongtharb A; Sthitmatee N PeerJ; 2024; 12():e17077. PubMed ID: 38500523 [TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical analysis of the tumour suppressor protein (p53) in feline neoplasia. Nasir L; Krasner H; Argyle DJ; Williams A Cancer Lett; 2000 Jul; 155(1):1-7. PubMed ID: 10814873 [TBL] [Abstract][Full Text] [Related]
19. Correlation Between Cyclo-oxygenase-2 and Vascular Endothelial Growth Factor Expression in Canine and Feline Squamous Cell Carcinomas. Millanta F; Andreani G; Rocchigiani G; Lorenzi D; Poli A J Comp Pathol; 2016 May; 154(4):297-303. PubMed ID: 27012907 [TBL] [Abstract][Full Text] [Related]
20. Complex carcinomas of the mammary gland in cats: pathological and immunohistochemical features. Seixas F; Pires MA; Lopes CA Vet J; 2008 May; 176(2):210-5. PubMed ID: 17459738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]